Summit Trail Advisors LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,426 shares of the conglomerate’s stock after buying an additional 555 shares during the period. Summit Trail Advisors LLC’s holdings in Danaher were worth $3,180,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher during the second quarter worth approximately $25,000. nVerses Capital LLC acquired a new position in Danaher during the second quarter worth approximately $25,000. MidAtlantic Capital Management Inc. acquired a new position in Danaher during the third quarter worth approximately $40,000. MFA Wealth Advisors LLC acquired a new position in Danaher during the second quarter worth approximately $51,000. Finally, Financial Connections Group Inc. acquired a new position in Danaher during the second quarter worth approximately $51,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Transactions at Danaher
In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Danaher
Danaher Stock Up 0.3 %
DHR opened at $235.84 on Friday. The business’s fifty day moving average is $258.15 and its two-hundred day moving average is $259.95. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market cap of $170.34 billion, a price-to-earnings ratio of 45.01, a PEG ratio of 4.32 and a beta of 0.85. Danaher Co. has a one year low of $215.68 and a one year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 earnings per share. Analysts anticipate that Danaher Co. will post 7.5 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. Danaher’s payout ratio is 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Consumer Discretionary Stocks Explained
- Disney’s Magic Strategy: Reinventing the House of Mouse
- What Are Dividend Achievers? An Introduction
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- 3 Fintech Stocks With Good 2021 Prospects
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.